Medicine

Grants

Grants per year 1991 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2034

• 1284 Active
• 5978 Finished

Grants per year

Search results

• Active

  Prot #IMM1104-101: A Phase 1/2a, Open-Label, Multicenter, Nonrandomized, Safety and Anti-tumor Activity Study of IMM-1-104, a Novel Oral Dual MEK1/2 Inhibitor in Participants with Previously Treated RAS-Mutated Advanced or Metastatic Solid Tumors

  Chandra, S. (PD/PI)

  Tempus Compass, LLC, Immuneering Corporation

  3/15/24 → 3/15/27

  Project: Research project

• Prot #M24-427: A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

  Mahalingam, D. (PD/PI)

  Parexel, AbbVie Inc.

  3/13/24 → 3/13/27

  Project: Research project

• Prot #KO-MEN-007: Phase 1 Study of Venetoclax/Azacitidine or Venetoclax in Combination with Ziftomenib (KO-539) or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination with Ziftomenib for the Treatment of Patients with Acute Myeloi

  Altman, J. K. (PD/PI)

  Quintiles, Inc., Kura Oncology, Inc.

  3/12/24 → 3/12/27

  Project: Research project

• Prot #GB002-3101: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH)

  Mylvaganam, R. J. (PD/PI)

  PPD Investigator Services, LLC, GB002, Inc.

  3/12/24 → 3/12/27

  Project: Research project

• Prot #Vedolizumab-4052: Re-define the IBD disease burden status

  Dulai, P. S. (PD/PI)

  Takeda Pharmaceuticals U.S.A., Inc.

  3/11/24 → 3/11/27

  Project: Research project

• Northwestern University CoFAR (NU-CoFAR) Clinical Research Center

  Gupta, R. S. (PD/PI), Berin, C. (Co-PD/PI), Eisenbarth, S. C. (Co-Investigator) & Williams, A. J. (Co-Investigator)

  National Institute of Allergy and Infectious Diseases

  3/11/24 → 2/28/31

  Project: Research project

• Modulation and exploitation of Siglec-6 function to broadly impede mast cell activation

  O'Sullivan, J. A. (PD/PI) & Bochner, B. S. (Other)

  National Institute of Allergy and Infectious Diseases

  3/7/24 → 1/31/29

  Project: Research project

• Prot #ATYR1923-C-005: Randomized, Double-Blind, Placebo-Controlled Proof-ofConcept Study to Evaluate the Efficacy, Safety and Tolerability of Efzofitimod in Patients With Systemic Sclerosis Related Interstitial Lung Disease

  Bemiss, B. (PD/PI)

  aTyr Pharma, Inc.

  3/7/24 → 3/7/27

  Project: Research project

• Covid-19 transmission, testing, and vaccination dynamics within migrant worker social networks

  Kandula, N. R. (PD/PI)

  The University of Chicago, National Institute of Allergy and Infectious Diseases

  3/5/24 → 1/31/26

  Project: Research project

• Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal medicines for Heart Failure with reduced ejection fraction: I-I-CAPTAIN

  Ahmad, F. S. (PD/PI), Ahmad, F. S. (PD/PI), Sweis, R. N. (Co-Investigator) & Sweis, R. N. (Co-Investigator)

  University of Colorado Denver, Patient-Centered Outcomes Research Institute

  3/1/24 → 3/1/29

  Project: Research project

• Gut microbiota metabolite sensing licenses IEC to cross talk with T cells to inhibit intestinal inflammation

  Cong, Y. (PD/PI), Yang, W. (Other), Yao, S. (Other) & Yu, T. (Other)

  National Institute of Diabetes and Digestive and Kidney Diseases

  3/1/24 → 1/31/27

  Project: Research project

• Prot #20210004: A Randomized, Open-Label, Phase 3 Study of Tarlatamab Compared With Standard of Care in Subjects With Relapsed Small Cell Lung Cancer After Platinum-Based First-Line Chemotherapy (DeLLphi-304)

  Patel, J. D. (PD/PI)

  Amgen, Inc.

  2/29/24 → 2/28/27

  Project: Research project

• Prot #STU00220812: FDA-AF Study: Fibricheck Detection cApabilities for Atrial Fibrillation - A Multicenter Validation Study

  Thomas, J. D. (PD/PI)

  Qompium NV

  2/28/24 → 2/28/27

  Project: Research project

• Prot #TVTX-RE021-204: A Multicentered, Single-Group Phase 2, Exploratory, OpenLabel Study to Investigate Safety and Effect of Sparsentan in Combination with Sodium Glucose Cotransporter-2 (SGLT2) Inhibition in the Treatment of Adult Participants with Immu

  Wadhwani, S. (PD/PI)

  George Clinical Pty Ltd., Retrophin, Inc.

  2/27/24 → 2/27/27

  Project: Research project

• Prot #CAB-201-001: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Systemic Lupus Erythematosus

  Blanco, I. (PD/PI), Wadhwani, S. (PD/PI) & Wadhwani, S. (PD/PI)

  Cabaletta Bio, Inc.

  2/26/24 → 8/30/27

  Project: Research project

• Novel Imaging approach for noninvasive and longitudinal monitoring of GBM responses to Immunotherapy

  Balyasnikova, I. V. (PD/PI), Procissi, D. (Co-Investigator) & Zhao, M. (Co-Investigator)

  Charlie Teo Foundation

  2/26/24 → 2/25/26

  Project: Research project

• Prot #IM027068: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

  Tomic, R. (PD/PI)

  Fortrea, Inc., Bristol-Myers Squibb Company

  2/23/24 → 2/23/27

  Project: Research project

• Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity

  Stoeger, T. (PD/PI)

  National Institute on Aging

  2/15/24 → 12/31/26

  Project: Research project

• Linking in vivo hemodynamics with outcomes in Type B aortic dissection using 4D flow MRI

  Allen, B. D. (PD/PI), Bagci, U. (Co-Investigator), Hoel, A. W. (Co-Investigator), Markl, M. (Co-Investigator), Mehta, C. (Co-Investigator), Ragin, A. (Co-Investigator) & Wilsbacher, L. D. (Co-Investigator)

  National Heart, Lung, and Blood Institute

  2/15/24 → 1/31/29

  Project: Research project

• Prot #EDGE-Lung: A Phase II, Open-Label, Platform Study, to Evaluate Immunotherapy-Based Combinations in Participants With Advanced Non-Small Cell Lung Cancer

  Patel, J. D. (PD/PI)

  ICON Clinical Research Limited, Gilead Sciences, Inc

  2/14/24 → 2/14/27

  Project: Research project

• Prot #M24-311: A Phase 2, Randomized Study to Evaluate Safety, Efficacy, and Optimal Dose of ABBV-400 in Combination with Fluorouracil, Folinic Acid, and Bevacizumab in Previously Treated Subjects with Unresectable Metastatic Colorectal Cancer

  Benson III, A. B. (PD/PI)

  AbbVie Inc.

  2/14/24 → 2/14/27

  Project: Research project

• Prot #XTMAB-16-202: A Long-Term Multicenter Open-Label Study to Evaluate the Long-Term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-Pulmonary Involvement

  Sporn, P. H. (PD/PI)

  Pharmaceutical Research Associates, Inc., Xentria, Inc.

  2/7/24 → 2/7/27

  Project: Research project

• Immune Mechanisms Regulating Allergy

  Eisenbarth, S. C. (PD/PI), Williams, A. J. (PD/PI) & Berin, C. (Co-Investigator)

  National Institute of Allergy and Infectious Diseases

  2/6/24 → 12/31/28

  Project: Research project

• Multidisciplinary NeuroAIDS Research and Training Program to Improve HIV Outcomes in Nigeria and Africa

  Gorelick, P. B. (PD/PI), Taiwo, B. O. (PD/PI), Taiwo, B. O. (PD/PI), Gorelick, P. B. (Co-Investigator), Gorelick, P. B. (Co-Investigator) & Newcomb, M. (Co-Investigator)

  John E. Fogarty International Center for Advanced Study in the Health Sciences

  2/1/24 → 12/31/28

  Project: Research project

• Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors

  Phillips, S. M. (PD/PI), Barber, E. L. (Co-Investigator), Gradishar, W. J. (Co-Investigator) & Spring, B. (Co-Investigator)

  National Cancer Institute

  2/1/24 → 1/31/26

  Project: Research project